Use of IQOSTM (a heated tobacco product) in Italy: A cross-sectional survey

Author:

Pellegatti Tommaso1,Paparatti Umberto di Luzio1

Affiliation:

1. Philip Morris Italia

Abstract

Abstract Background: Limited data are available on the use of heated tobacco products (HTPs) and specifically the use of IQOS™ in Italy. Here, we present the results of a cross-sectional survey on a randomly selected sample of registered of IQOS™ legal age users with the aim of assessing their use behaviors associated with IQOS™ and previous tobacco use history to better understand patterns of IQOS™ use at individual and population levels in Italy. Methods: A quantitative survey on 3002 interviews was conducted from May 20 to May 26, 2020, on a sample of IQOS™ users of both sexes, aged 18-80 years and who had used at least 100 tobacco units (HEETSTM) in their lifetime. Results: The mean age at the time of starting using IQOSTM was 36.3 years. Only 0.8% had started regularly (at least 1 HEETSTM per day) using IQOS™ at 16-<18 years, whereas the majority started at 25-44 years (52.5%). For 64% of respondents, IQOS™ was their exclusive tobacco product, whereas 36% used IQOS™ in combination with another tobacco and/or nicotine product (TNP) (mainly IQOS™ and cigarettes: 25%). Ninety percent of IQOS™ users were cigarette smokers (89.7%) or e-cigarette users (0.3%) at the time when they started using IQOS™. Only 0.6% had never smoked, and 8.3% were former cigarette smokers or e-cigarette users when they started to use IQOS™. Conclusions: The vast majority of respondents were already smokers when they switched to IQOS™, suggesting that the product does not pose a strong risk of attracting nicotine-naïve users. Further, most IQOS™ users in this survey reported they no longer smoke cigarettes. Our findings indicate that the use of alternative TNPs has the potential to reduce the number of cigarette smokers in Italy.

Publisher

Research Square Platform LLC

Reference37 articles.

1. 1. Perra A, De Mei B, Cattaneo C, Salmaso S. Chronic Non-Communicable Diseases (NCDs): the challenge of the century, also for our country. 2012. https://www.epicentro.iss.it/ben/2012/marzo/2. Accessed on June 1, 2021.

2. 2. WHO. Non communicable diseases. https://www.who.int/health-topics/noncommunicable-diseases#tab=tab_1. Accessed on April 29, 2022.

3. 3. Italian Association for Cancer Registries. AIRTUM-AIOM. The cancer numbers in Italy. 2016. http://www.registri-tumori.it/PDF/AIOM2016/I_numeri_del_cancro_2016.pdf. Accessed on June 1, 2021.

4. 4. Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61:1043-47. https://doi.org/10.1136/thx.2006.064410.

5. 5. Pan B, Jin X, Jun L, Qiu S, Zheng Q, Pan M. The relationship between smoking and stroke: A meta-analysis. Medicine (Baltimore). 2019;98(12):e14872. https://doi.org/10.1097/MD.0000000000014872.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3